ebselen has been researched along with Candidiasis, Vulvovaginal in 3 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
Candidiasis, Vulvovaginal: Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Liang, X | 1 |
Menon, S | 3 |
Vartak, R | 3 |
Gaida, R | 1 |
Wojaczyńska, E | 1 |
Patel, K | 3 |
Billack, B | 3 |
Patki, M | 1 |
Jablonski, J | 1 |
Mediouni, S | 1 |
Fu, Y | 1 |
Valente, ST | 1 |
3 other studies available for ebselen and Candidiasis, Vulvovaginal
Article | Year |
---|---|
Nanoformulation of a novel potent ebselen analog for treatment of vulvovaginal candidiasis.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Vulvovaginal; Female; Humans; Iso | 2023 |
β-cyclodextrin polymer/Soluplus® encapsulated Ebselen ternary complex (EβpolySol) as a potential therapy for vaginal candidiasis and pre-exposure prophylactic for HIV.
Topics: Antifungal Agents; Azoles; Candidiasis, Vulvovaginal; Cellulose; Cyclodextrins; Female; HeLa Cells; | 2020 |
Evaluation of the antifungal activity of an ebselen-loaded nanoemulsion in a mouse model of vulvovaginal candidiasis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Disease Models, Animal; Emu | 2021 |